These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Inflammatory cytokines and the GH/IGF-I axis: novel actions on bone growth. Pass C; MacRae VE; Ahmed SF; Farquharson C Cell Biochem Funct; 2009 Apr; 27(3):119-27. PubMed ID: 19330796 [TBL] [Abstract][Full Text] [Related]
45. Insulin-like growth factor-I receptor signal transduction and the Janus Kinase/Signal Transducer and Activator of Transcription (JAK-STAT) pathway. Himpe E; Kooijman R Biofactors; 2009; 35(1):76-81. PubMed ID: 19319849 [TBL] [Abstract][Full Text] [Related]
46. The role of growth hormone in the pathogenesis of diabetic kidney disease. Flyvbjerg A Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():525-9. PubMed ID: 16444187 [TBL] [Abstract][Full Text] [Related]
47. [The cytokine system of bone tissue]. Stilgren LS; Abrahamsen B; Abdallah BM; Jørgensen NR Ugeskr Laeger; 2005 Feb; 167(8):874-8. PubMed ID: 15789838 [No Abstract] [Full Text] [Related]
48. Diabetes and suppressors of cytokine signaling proteins. Rønn SG; Billestrup N; Mandrup-Poulsen T Diabetes; 2007 Feb; 56(2):541-8. PubMed ID: 17259405 [No Abstract] [Full Text] [Related]
50. Sodium/potassium-coupled glutamate transporters, a "new" family of eukaryotic proteins: do they have "new" physiological roles and could they be new targets for pharmacological intervention? Danbolt NC; Storm-Mathisen J; Ottersen OP Prog Brain Res; 1994; 100():53-60. PubMed ID: 7938534 [No Abstract] [Full Text] [Related]
51. Burns and metabolism. Hasselgren PO J Am Coll Surg; 1999 Feb; 188(2):98-103. PubMed ID: 10024150 [No Abstract] [Full Text] [Related]
52. A new perspective on deoxynivalenol and growth suppression. Voss KA Toxicol Sci; 2010 Feb; 113(2):281-3. PubMed ID: 19933702 [No Abstract] [Full Text] [Related]